Marko Mihajlovic
Papers
2
Total Citations
4
H-Index
2
About
Marko Mihajlovic is pioneering the intersection of biomaterials and automation to transform drug development. His research focuses on engineering physiologically relevant cell culture platforms, specifically addressing the critical gap between traditional plastic/glass-based systems and the need for scalable, high-throughput screening (HTS) technologies. Mihajlovic’s major contributions center on the development of hydrogel-based cell culture environments that better mimic native tissue, overcoming the limitations of conventional substrates that undermine predictive power in drug testing. His landmark works, including the HYDRA system (2024) and its subsequent detailed fabrication protocol (2025), introduce a robotic liquid handling automation approach for creating cell culture hydrogels. This innovation directly tackles the challenge of curved menisci in HTS plates, enabling reproducible, high-throughput drug testing with enhanced biomimicry. While his most-cited papers currently hold 2 citations each, they represent foundational steps toward a paradigm shift in preclinical drug development—moving beyond organoids and organs-on-chip, which lack early-stage scalability. Mihajlovic’s work is particularly notable for its practical, automation-ready design, positioning him as a key figure in bridging biomaterials engineering with industrial-scale pharmaceutical screening.
Research Focus
Key Achievements
Top Papers
- 1
- 2